1 active not recruiting, 1 completed, 1 recruiting. 3 Phase 1, 1 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 1 | 3 | Active not recruiting 1, Completed 1, Recruiting 1 |
| Phase 2 | 1 | Completed 1 |
Follow Diffusion Weighted Imaging: new trials by email Literature Review of Diffusion Weighted Imaging trials Research Report on Diffusion Weighted Imaging
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| PET/MRI, 18F-FDG PET/CT and Whole Body MRI in Finding Extramedullary Myeloid Leukemia in Patients With Newly Diagnosed Acute Myeloid Leukemia Computed Tomography, Diffusion Weighted Imaging, Fludeoxyglucose F-18 - Acute Myeloid Leukemia, Acute Promyelocytic Leukemia With PML-RARA | Phase 1 | Recruiting | M.D. Anderson Cancer Center | 77 | 2020-07-15 | 2026-10-13 |
| Pembrolizumab in Treating Younger Patients With Recurrent, Progressive, or Refractory High-Grade Gliomas, Diffuse Intrinsic Pontine Gliomas, Hypermutated Brain Tumors, Ependymoma or Medulloblastoma Biospecimen Collection, Conventional Magnetic Resonance Imaging, Diffusion Tensor Imaging - Constitutional Mismatch Repair Deficiency Syndrome, Lynch Syndrome | Phase 1 | Active not recruiting | National Cancer Institute (NCI) | 71 | 2015-06-03 | 2026-07-20 |
| Cediranib, Temozolomide, and Radiation Therapy in Treating Patients With Newly Diagnosed Glioblastoma Cediranib Maleate, Diffusion Tensor Imaging, Diffusion Weighted Imaging - Adult Giant Cell Glioblastoma, Adult Glioblastoma | Phase 1 / Phase 2 | Completed | National Cancer Institute (NCI) | 46 | 2008-04-01 | 2023-06-06 |
Brain Neoplasms (1) · Colorectal Neoplasms, Hereditary Nonpolyposis (1) · Diffuse Intrinsic Pontine Glioma (1) · Ependymoma (1) · Familial ependymoma (1) · Glioblastoma (1) · Glioma (1) · Gliosarcoma (1) · Leukemia, Myeloid, Acute (1) · Leukemia, Promyelocytic, Acute (1) · Medulloblastoma (1) · Turcot syndrome (1)
National Cancer Institute (NCI) (2) · M.D. Anderson Cancer Center (1)
United States (3) · Canada (1)
Dawid Schellingerhout (1) · Elizabeth R Gerstner, MD (1) · Eugene I Hwang (1)
PMID 24309981, PMID 25113840, PMID 33842889, PMID 38197800
P30CA006516 (1), R01CA129371 (1), UM1CA081457 (1)